This is NOT investment advice: My opinion of what's

New Post Public Reply Private Reply Replies (0) Message Board
joey68
This is NOT investment advice:

My opinion of what's happening..
Opinion obviously means this is NOT investment advice, right?
As in.. go call your broker with financial / investing questions and do NOT base your investment decisions on this or any of my posts.

Anyways..
How many people are keeping up with those MA lines?

I use these parameters in order to see momentum (read previous post):
50MA
100MA
200MA

Even though the PPS has gone down again today, notice now that the 50MA and 100MA are only .0002 away from crossing. This means that even though we closed red the past 3 days, momentum is still building.

Companies are like investors. They only want what's best. Companies don't want fickle pickle investors. They want people willing to stay with them long term. Why? Would you want 1,000 people emailing, calling, and writing letters whining and complaining about the share price and wanting to know 'when are you going to make me a millionaire?' I know I wouldn't want that.

Short term investors place extra burdens on companies because they are skittish about volatility. Unlike short term investors who base the majority of their investment decisions on the color of a candle, long term investors help create value.

Long term investors don't only try to average down, they try to average UP; meaning, they buy shares as the price goes UP. It's called Pyramiding. Google it. Its very interesting stuff. As the price goes up, they continually buy less number of shares for a higher price.

Why do investors average up? Because it only further enhances the value of the company. Whats the point in averaging down and owning 50 million shares in one company if you only buy as the price goes down? (There's nothing wrong with owning millions of shares; the point being its important to know when to SELL).

Many investors fall for the 'its a gift' thing far too often.

On the other hand, averaging UP increases the stocks visibility to more investors.

Many investors average down with the notion that they are getting shares at 'value' prices. They say things such as:

"Just bought another 100,000 on this dip!"
or
"These are gift prices! Get them while you can!"

I respect investors decisions to think like this, but for myself, the thinking is backwards. Averaging up reassures you that you found a great stock. Averaging down can actually hurt you because when you average down, your position keeps getting bigger, and if the stock never recovers, your losses will end up being greater than if you simply kept your original position. The downfall for many investors is not knowing when to SELL. They stay in, watch the price skyrocket, but never sell thinking it will go higher. But the price crashes and end up taking a total loss. Those 50 million 'gift' shares are now worth nothing.


So what's the point of all this rambling?

I think the people behind Spectrascience are smarter than many of us give them credit. I think the men and women behind SCIE know 2016 - 2017 is going to be the year sales are reintroduced and they want as many serious, long term investors, who will add value to their company as possible. And they are being very strategic about it.

First off, we got a PR yesterday. And it was a great PR. It only was meant for sales in the UK and was not a requirement for Spain, Europe, or Saudi Arabia. This is great for us because it to me it says sales are ready to go in Europe.

Second, where is this 10K? I'm not asking because I'm nervous. I'm asking because I'm loving that its not out yet. Why? Because like I said above, SCIE wants the fickle pickle investors out because they know their company is about to show sales in the 2016-2017 year, and by holding off on the 10K until after market closes (or at least later in the day), it sets up tomorrow for a period of switching hands.

Weaker investors will sell because the 10K didn't make them 'millionaires', and stronger investors will buy and hold. And as the share price goes up, weaker investors wont be willing to pay a higher share price, which will lock them out of the company, leaving shares only in strong investors hands.

I truly believe investing is survival of the fittest. Compare the number of investors who have become millionaires to those who have sold at the first sign of trouble, gave up, and moved on. The majority of us aren't willing to research a company, and simply jump in to any investment which seems promising. This is a recipe for disaster.

Unlike short term investors who get in and out, long term investors do DD not only on the company (SCIE) but also research the industry and question what changes are currently happening in the industry?

I think some of the best investments are those that continually improve their product. Spectrascience has done this for years.
WavSTAT1. Obsolete.
WavSTAT2. Obsolete
WavSTAT3. Obsolete.
WavSTAT4. Current.

To the surprise of many investors, some of the best (and most successful) companies are those that grow slowly. Ever hear of the saying "run this like a marathon not a sprint"?
Companies that tend to sprint often flop before ever reaching the finish line.
Spectrascience is a slow growth company, which has a real product, government approvals, and soon to be sales. SCIE is definitely a marathon runner.

In conclusion, I see SCIE as a long term investment. I think they are holding off on the 10K for a reason and I believe the PR yesterday was a strategic play on their part. I don't think its worth selling for a small profit right now because the capital gain taxes would cost almost the same as what it would take to create a new position if the price were to increase.

This and every post of mine is NOT investment advice.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 86

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 77

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading
Langford Chosen for Navy Mutual's 2026 Bolles Award

Updated Category News Views 225

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Continue Reading
Millrose Properties Faces Legal Storm: Investors Alerted

Updated Category News Views 187

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 157

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 65

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 116

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
UBCF Strikes Big in Times Square with New Billboards

Updated Category News Views 113

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 173

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 156

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading

Top 5 Most Recently Viewed Articles

EarthCam Unveils Revolutionary AI Camera for Construction Safety

Updated Category News Views 302

EarthCam Launches AI-Powered Mobile StreamCam Robotic EarthCam, a leader in visual technology, has unveiled its new Mobile StreamCam Robotic aimed at enhancing monitoring capabilities in interior construction. This innovative camera is designed to combine advanced live-streaming features with smart AI insights, providing construction teams with real-time data and...

Continue Reading
Investors Should Act Now: iLearningEngines Class Action News

Updated Category News Views 140

Understanding the iLearningEngines Class Action Lawsuit The well-regarded law firm Faruqi & Faruqi, LLP is currently inviting investors of iLearningEngines, Inc. to stay informed about an important class action lawsuit. This lawsuit revolves around allegations that iLearningEngines engaged in misleading practices fundamentally impacting its investors. The deadline to seek...

Continue Reading
Sarepta's Gene Therapy Under Investigation Following Tragic Death

Updated Category News Views 130

Investigation into Elevidys Following a Tragic Incident The U.S. Food and Drug Administration (FDA) has begun an investigation into the unfortunate death of a young boy who was administered Elevidys, Sarepta Therapeutics Inc.’s gene therapy designed for treating Duchenne muscular dystrophy. This announcement came after market close, raising concerns regarding the safety...

Continue Reading
2Rivers Group Enhances Market Position in West Africa

Updated Category News Views 56

2Rivers Group Expands Operations into West Africa 2Rivers Group is excited to announce its ongoing expansion into the West African market, reinforcing its status as a key entity in the global energy trading and distribution landscape. This initiative aligns perfectly with the company’s vision of achieving sustainable growth in important markets around the world....

Continue Reading
Pathward Financial Announces Upcoming Q1 2025 Earnings Call

Updated Category News Views 189

Pathward Financial to Announce Earnings for First Quarter 2025 Pathward Financial, Inc. has made an important announcement regarding its upcoming financial results for the first quarter of fiscal year 2025. The release is set for Tuesday, after the market closes, and the company is eager to share insights from these results. Conference Call Scheduled A conference call and...

Continue Reading